Myocyte Enhancer Factor 2C (MEF2C) (Middle Region) Peptide
Quick Overview for Myocyte Enhancer Factor 2C (MEF2C) (Middle Region) Peptide (ABIN5513413)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- LMGGDLTSGA GTSAGNGYGN PRNSPGLLVS PGNLNKNMQA KSPPPMNLGM
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-MEF2C Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MEF2C (Myocyte Enhancer Factor 2C (MEF2C))
-
Background
-
This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe mental retardation, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described.
Alias Symbols: MEF2C,
Protein Size: 417 -
Gene ID
- 4208
Target
-